KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Thermo Fisher Scientific (TMO) Enterprise Value (2016 - 2025)

Thermo Fisher Scientific's Enterprise Value history spans 17 years, with the latest figure at -$10.0 billion for Q4 2025.

  • For the quarter ending Q4 2025, Enterprise Value fell 78.17% year-over-year to -$10.0 billion, compared with a TTM value of -$10.0 billion through Dec 2025, down 78.17%, and an annual FY2025 reading of -$10.0 billion, down 78.17% over the prior year.
  • Enterprise Value for Q4 2025 was -$10.0 billion at Thermo Fisher Scientific, down from -$3.5 billion in the prior quarter.
  • The five-year high for Enterprise Value was -$1.8 billion in Q3 2022, with the low at -$12.0 billion in Q4 2021.
  • Average Enterprise Value over 5 years is -$5.9 billion, with a median of -$5.9 billion recorded in 2023.
  • Year-over-year, Enterprise Value surged 76.72% in 2022 and then tumbled 188.34% in 2024.
  • Tracing TMO's Enterprise Value over 5 years: stood at -$4.4 billion in 2021, then crashed by 93.07% to -$8.4 billion in 2022, then rose by 5.3% to -$8.0 billion in 2023, then rose by 29.63% to -$5.6 billion in 2024, then tumbled by 78.17% to -$10.0 billion in 2025.
  • Per Business Quant, the three most recent readings for TMO's Enterprise Value are -$10.0 billion (Q4 2025), -$3.5 billion (Q3 2025), and -$6.3 billion (Q2 2025).